Benzinga | Jun 15, 2021 10:31AM EDT

Immatics Granted U.S. Patent Titled 'Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers'

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6664&f=G&l=50&d=PTXT&p=134&S1=20210615&OS=20210615&RS=20210615